# Epinephrine Versus Isoprenaline During Out-of-Hospital Cardiac Arrest With Asystole

Study · id `cardio:ct-nct06473116` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06473116](<https://clinicaltrials.gov/study/NCT06473116>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06473116

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1178 participants.

## Technical summary

Registry record NCT06473116. Randomized; no masking; primary purpose treatment. Start 2025-03 (anticipated); primary completion 2029-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1178 participants (planned count; ClinicalTrials.gov record NCT06473116, source copy `cardio:ctgov-nct06473116-2024-06-25`, retrieved 2026-10-26)
- Planned start: 2025-03 (anticipated) (ClinicalTrials.gov record NCT06473116, source copy `cardio:ctgov-nct06473116-2024-06-25`, retrieved 2026-10-26)
- Primary completion: 2029-07 (anticipated) (ClinicalTrials.gov record NCT06473116, source copy `cardio:ctgov-nct06473116-2024-06-25`, retrieved 2026-10-26)
- Completion: 2029-07 (anticipated) (ClinicalTrials.gov record NCT06473116, source copy `cardio:ctgov-nct06473116-2024-06-25`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT06473116, source copy `cardio:ctgov-nct06473116-2024-06-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06473116-2024-06-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Epinephrine Versus Isoprenaline During Out-of-Hospital Cardiac Arrest With Asystole
- Acronym: EPISO
- Condition: Out-Of-Hospital Cardiac Arrest
- Intervention (Drug): Isoprenaline Only Product
- Lead sponsor: University of Southern Denmark
- Lead sponsor class: OTHER
- Collaborator: Odense University Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry lists this organization as the lead sponsor: University of Southern Denmark (`cardio:org-university-of-southern-denmark`)
- Registry lists this organization as a collaborator: Odense University Hospital (`cardio:org-odense-university-hospital`)

## Provenance

Content hash: cb747dab4bf05a5685cbfa17ba8dd34d370e222a0fc9ec32b73ca54ff1ea558e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
